FTC’s “vague standard” on trial
This article was originally published in The Tan Sheet
Executive Summary
The Federal Trade Commission "is unlawfully trying to suppress...commercial free speech protected by the First Amendment through imposition of a vague substantiation standard for advertised claims," according to a lawsuit filed in Utah district court by Relacore marketer Carter-Reed Dec. 13. Claims for C-R's stress-reliever and "belly-fat" reducer dietary supplement initially were cited by the National Advertising Division, and subsequently referred to FTC (1"The Tan Sheet" June 28, 2004, In Brief). FTC then threatened Carter-Reed with law enforcement action for making false and misleading claims for the cortisol-containing product. The firm is seeking to enjoin the FTC from suppressing advertised claims for Relacore under the FTC Act's "competent and reliable scientific evidence" standard...
You may also be interested in...
NAD sheds weight claims, adds to FTC’s load
Print and broadcast advertising for Carter-Reed's Relacore has been referred to the Federal Trade Commission after the firm's "failure to provide a substantive response" to NAD's inquiry, the watchdog group states in an upcoming Case Reports. The Council of Better Business Bureaus division came across the claims "A natural feel-good pill called Relacore might be the perfect answer to belly fat" and "The most significant weight-control advancement in more than a decade" during a routine review. Carter-Reed said "it had prepared a confidential submission for NAD," but never submitted the statement...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.